Low bleeding rates after intramuscular Covid‐19 vaccination in patients with haemophilia and von Willebrand disease: Outcome data from the Swedish haemophilia registry-Reference-Cited by-同舟云学术

Low bleeding rates after intramuscular Covid‐19 vaccination in patients with haemophilia and von Willebrand disease: Outcome data from the Swedish haemophilia registry

Published:2024-06-06 Issue:5 Volume:30 Page:1217-1220
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Andersson Nadine G.¹²³^ORCID,Brange Hannes³,Astermark Jan¹⁴^ORCID,Axelsson Malin¹,Baghaei Fariba⁵^ORCID,Magnusson Maria⁶⁷⁸⁹^ORCID,Olsson Anna⁵^ORCID,Olsson Elsa⁷,Ranta Susanna⁸¹⁰^ORCID,Westesson Linda Myrin⁵¹¹^ORCID,Holmström Margareta⁷¹²

Affiliation:

1. Centre for Thrombosis and Haemostasis Skåne University Hospital Malmö Sweden

2. Department of Clinical Sciences and Paediatrics Lund University Lund Sweden

3. Children´s Hospital Skåne University Hospital Malmö Sweden

4. Department of Translational Medicine Lund University Lund Sweden

5. Department of Medicine, Region Västra Götaland Sahlgrenska University Hospital Gothenburg Sweden

6. Clinical Chemistry and Blood Coagulation Research, Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm Sweden

7. Coagulation Unit, Department of Haematology Karolinska University Hospital Stockholm Sweden

8. Astrid Lindgren Children's Hospital Karolinska University Hospital Stockholm Sweden

9. Division of Paediatrics, Department of Clinical Science, Intervention and Technology Karolinska Institutet Stockholm Sweden

10. Childhood Cancer Research Unit, Department of Women's and Children's Health Karolinska Institutet Stockholm Sweden

11. Sahlgrenska Academy Institution for Nursing Science and Health at Gothenburg University Gothenburg Sweden

12. Department of Health, Medicine and Caring Sciences Linköping University Linköping Sweden

Funder

Sveriges Kommuner och Landsting

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.15063

Reference8 articles.

1. WFH Guidelines for the Management of Hemophilia, 3rd edition

2. Immunogenicity and safety of intramuscular versus subcutaneous administration of a combined measles, mumps, rubella, and varicella vaccine to children 12 to 18 months of age

3. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

4. Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?

5. Prevalence of COVID‐19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe